Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98 ; volume:21 ; number:1 ; day:22 ; month:2 ; year:2019 ; pages:1-11 ; date:12.2019
Breast cancer research ; 21, Heft 1 (22.2.2019), 1-11, 12.2019
- Creator
-
Kensler, Kevin H.
Regan, Meredith M.
Heng, Yujing J.
Baker, Gabrielle M.
Pyle, Michael E.
Schnitt, Stuart J.
Hazra, Aditi
Kammler, Roswitha
Thürlimann, Beat
Colleoni, Marco
Viale, Giuseppe
Brown, Myles
Tamimi, Rulla M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-019-1118-z
- URN
-
urn:nbn:de:101:1-2019032023311442787328
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kensler, Kevin H.
- Regan, Meredith M.
- Heng, Yujing J.
- Baker, Gabrielle M.
- Pyle, Michael E.
- Schnitt, Stuart J.
- Hazra, Aditi
- Kammler, Roswitha
- Thürlimann, Beat
- Colleoni, Marco
- Viale, Giuseppe
- Brown, Myles
- Tamimi, Rulla M.
- SpringerLink (Online service)
Other Objects (12)
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
SPDEF Regulates Fatty Acid Metabolism Driving Tumor Growth in Androgen Receptor-Positive Breast Cancer
Rat Models of Hormone Receptor-Positive Breast Cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
SPDEF Regulates Fatty Acid Metabolism Driving Tumor Growth in Androgen Receptor-Positive Breast Cancer
Rat Models of Hormone Receptor-Positive Breast Cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
SPDEF Regulates Fatty Acid Metabolism Driving Tumor Growth in Androgen Receptor-Positive Breast Cancer
Rat Models of Hormone Receptor-Positive Breast Cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients